Allogene Therapeutics, Inc. (ALLO)
2.30
-0.01
(-0.43%)
USD |
NASDAQ |
Mar 06, 16:00
2.29
-0.01
(-0.43%)
After-Hours: 20:00
Allogene Therapeutics SG&A Expense (TTM) : 58.53M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 317.74M |
| Agenus, Inc. | 63.03M |
| Curis, Inc. | 14.52M |
| Plus Therapeutics, Inc. | 11.09M |
| Windtree Therapeutics, Inc. | 7.706M |